​

Eledon Pharmaceuticals Ownership | Who Owns Eledon Pharmaceuticals?

OverviewRevenueFinancialsChart

Eledon Pharmaceuticals Ownership Summary

Eledon Pharmaceuticals is owned by 35.59% institutional investors, 0.04% insiders, and 64.37% retail investors. Bvf inc/il is the largest institutional shareholder, holding 20.98% of ELDN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.07% of its assets in Eledon Pharmaceuticals shares.

ELDN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockEledon Pharmaceuticals35.59%0.04%64.37%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bvf inc/il6.29M20.98%$16.61M
Armistice capital2.34M7.79%$6.17M
Zimmer partners, lp2.11M7.03%$5.57M
Schonfeld strategic advisors1.50M5.00%$3.96M
Sphera funds management1.30M4.32%$3.42M
Vanguard group1.10M3.68%$2.92M
Woodline partners lp675.24K2.25%$1.78M
Nantahala capital management600.00K2.00%$1.58M
Alyeska investment group500.00K1.67%$1.32M
Ensign peak advisors443.00K1.48%$1.17M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sphera funds management1.30M0.47%$3.42M
Bvf inc/il6.29M0.47%$16.61M
Cm management160.00K0.39%$422.40K
Zimmer partners, lp2.11M0.10%$5.57M
Nantahala capital management600.00K0.09%$1.58M
Inspire investing194.69K0.09%$802.12K
Armistice capital2.34M0.08%$6.17M
Jmac enterprises58.04K0.04%$239.13K
Schonfeld strategic advisors1.50M0.03%$3.96M
Clarity capital partners11.50K0.02%$47.38K

Top Buyers

HolderShares% AssetsChange
Zimmer partners, lp2.11M0.10%2.11M
Bvf inc/il6.29M0.47%1.97M
Schonfeld strategic advisors1.50M0.03%1.45M
Sphera funds management1.30M0.47%1.30M
Nantahala capital management600.00K0.09%600.00K

Top Sellers

HolderShares% AssetsChange
Susquehanna group, llp21.79K--77.99K
Millennium management---13.88K
Citadel advisors---1.40K
Wells fargo & company/mn---189.00
Group one trading---22.00

New Positions

HolderShares% AssetsChangeValue
Zimmer partners, lp2.11M0.10%2.11M$5.57M
Sphera funds management1.30M0.47%1.30M$3.42M
Nantahala capital management600.00K0.09%600.00K$1.58M
Alyeska investment group500.00K0.01%500.00K$1.32M
Inspire investing194.69K0.09%194.69K$802.12K

Sold Out

HolderChange
Group one trading-22.00
Wells fargo & company/mn-189.00
Citadel advisors-1.40K
Millennium management-13.88K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2024336.45%18,485,8271.24%350.96%12-42.86%6500.00%
Jun 30, 2024313.33%18,259,81090.30%603.88%2190.91%1-85.71%
Mar 31, 2024303.45%9,595,0614.83%394.25%11-8.33%716.67%
Dec 31, 2023293.57%9,153,1682.64%302.21%129.09%6-33.33%
Sep 30, 202328-15.15%8,917,867-3.86%370.88%11-31.25%980.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.83M3.07%-
Vanguard Institutional Extnd Mkt Idx Tr974.99K1.63%443.00K
Fidelity Extended Market Index218.99K0.37%-1.44K
Inspire Fidelis Multi Factor ETF194.69K0.33%-
iShares Micro-Cap ETF131.13K0.22%-
Extended Equity Market Fund K121.13K0.20%41.72K
BlackRock Extended Equity Market K79.41K0.20%-34.00
EAM Ultra Micro Cap109.56K0.18%-5.91K
Fidelity Total Market Index73.51K0.12%16.89K
NT Ext Equity Mkt Idx Fd - L67.72K0.11%27.53K

Recent Insider Transactions

DateNameRoleActivityValue
Oct 29, 2024BVF PARTNERS L P/IL-Buy$440.49
Oct 29, 2024BVF PARTNERS L P/IL-Buy$2.10K
Oct 29, 2024BVF PARTNERS L P/IL-Buy$2.21K
May 09, 2024BVF PARTNERS L P/IL-Buy$1.95M
May 09, 2024BVF PARTNERS L P/IL-Buy$232.07

Insider Transactions Trends

DateBuySell
2024 Q43-
2024 Q26-
2023 Q4--
2023 Q29-
2023 Q1--

ELDN Ownership FAQ

Who Owns Eledon Pharmaceuticals?

Eledon Pharmaceuticals shareholders are primarily institutional investors at 35.59%, followed by 0.04% insiders and 64.37% retail investors. The average institutional ownership in Eledon Pharmaceuticals's industry, Biotech Stocks , is 109.70%, which Eledon Pharmaceuticals falls below.

Who owns the most shares of Eledon Pharmaceuticals?

Eledon Pharmaceuticals’s largest shareholders are Bvf inc/il (6.29M shares, 20.98%), Armistice capital (2.34M shares, 7.79%), and Zimmer partners, lp (2.11M shares, 7.03%). Together, they hold 35.81% of Eledon Pharmaceuticals’s total shares outstanding.

Does Blackrock own Eledon Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Eledon Pharmaceuticals.

Who is Eledon Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Sphera funds management is Eledon Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.47% of its assets in 1.3M Eledon Pharmaceuticals shares, valued at 3.42M$.

Who is the top mutual fund holder of Eledon Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Eledon Pharmaceuticals shares, with 3.07% of its total shares outstanding invested in 1.83M Eledon Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools